Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. (SZSE: 300313)
Health Care · Biotechnology · CN
CN¥12.80
+43.18% today · +45.8% 1Y
Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. (SZSE: 300313) operates in the Biotechnology industry within the Health Care sector. The company is valued at $456.56M and employs 116 people.
Over the last twelve months the share price has gained 45.8%, trading between 6.89 and 15.41.
Tweenvest scores Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. across four factors: quality 40/100, value 75/100, growth 8/100. Its strongest factor is value.
300313 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $456.56M
- Revenue (TTM)
- $42.66M
- P/E
- —
- EPS
- -0.06
- Dividend yield
- —
- Beta (5Y)
- 0.10
- 52-week high
- CN¥15.41
- 52-week low
- CN¥6.89
- Avg volume (3M)
- —
- Shares outstanding
- 239.78M
- Employees
- 116
- Next earnings
- —
About Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd.
Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. (300313.SZ) is a Chinese enterprise primarily focused on cattle and sheep farming. The company utilizes advanced biological genetic technology to enhance livestock breeds, supplying embryos, other genetic resources, and relevant services to the animal husbandry sector. Furthermore, its operations span the complete beef production chain, including breeding, fattening, slaughtering, processing, and marketing beef cattle, alongside the processing of mutton products. Founded in 2003, the company is headquartered in Changji, China.
- ISIN
- CNE100001D62
- Founded
- 2003
- Listed since
- Apr 25, 2012
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $263.50 | -0.55% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $440.55 | +0.28% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $144.90 | -0.83% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.37 | +0.06% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $823.94 | -1.21% |
| argenx SEENXTBR: ARGX | $65.85B | €867.40 | -3.84% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $135.64 | -6.50% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.